Restore Compassionate Care

Restore Compassionate Care provides Spravato at its Boardman location in Youngstown, Ohio for adults whose depression has not responded to at least two antidepressants, as well as those with major depressive disorder and acute suicidal ideation. The esketamine nasal spray targets NMDA receptors in the brain and can offer rapid relief from depressive symptoms.

Spravato is administered in person as required by the REMS program. Patients self-administer the nasal spray in a monitored room and remain for about two hours of observation. The typical schedule is twice weekly for the first four weeks, followed by a tapering phase.

Spravato is prescribed only after a thorough psychiatric evaluation and medical screening. The Boardman team supports patients with insurance coordination and benefits guidance as part of an evidence-based, compassionate approach to care.